Format

Send to:

Choose Destination
See comment in PubMed Commons below
Hum Gene Ther. 1998 Feb 10;9(3):295-304.

Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.

Author information

  • 1Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland 97201, USA.

Abstract

Previously, this lab has reported the use of hepatocyte transplantation and in vivo gene therapy for the correction of a mouse model of Hereditary Tyrosinemia Type I (HT1). Here, we demonstrate repopulation of fumarylacetoacetate hydrolase (FAH)-deficient livers with cultured hepatocytes. Correction of the disease phenotype was achieved by retrovirally transducing cultured FAH- hepatocytes ex vivo, followed by transplantation and selective repopulation. Treated mice were phenotypically normal and had corrected plasma amino acid levels and liver function tests. Our results demonstrate that efficient hepatic repopulation using ex vivo genetically manipulated hepatocytes is feasible.

PMID:
9508047
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Write to the Help Desk